Hai-ling W. Qiao

40 Daxue Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

A novel CYP2E1 inhibitor, 4-Methyl-5-Acetylthiazole, mitigates LPS-induced acute lung injury by suppressing macrophage-mediated inflammation and preserving mitochondria.

A novel CYP2E1 inhibitor, 4-Methyl-5-Acetylthiazole, mitigates LPS-induced acute lung injury by suppressing macrophage-mediated inflammation and preserving mitochondria.

Journal: Free radical biology & medicine

Published: January 22, 2026

Clinical discovery of anti-CYP2E1 autoantibodies and preclinical efficacy of a CYP2E1 inhibitor in rheumatoid arthritis.

Clinical discovery of anti-CYP2E1 autoantibodies and preclinical efficacy of a CYP2E1 inhibitor in rheumatoid arthritis.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: December 24, 2025

Impact of POR and cytochrome b5 variability on the genotype-phenotype discordance of CYP2A6 and CYP2D6: A quantitative analysis in Chinese human livers.

Impact of POR and cytochrome b5 variability on the genotype-phenotype discordance of CYP2A6 and CYP2D6: A quantitative analysis in Chinese human livers.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: December 17, 2025

4-Methyl-5-Acetylthiazole (Q11), a novel CYP2E1 inhibitor, has a protective effect on the hepatotoxicity induced by acetaminophen.

4-Methyl-5-Acetylthiazole (Q11), a novel CYP2E1 inhibitor, has a protective effect on the hepatotoxicity induced by acetaminophen.

Journal: Bioorganic chemistry

Published: October 15, 2025

Dual effects of a new CYP2E1 inhibitor on gout: Anti-inflammatory actions and lowered uric acid levels.

Dual effects of a new CYP2E1 inhibitor on gout: Anti-inflammatory actions and lowered uric acid levels.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: August 06, 2025

Protective effect of mannose oligosaccharides on cadmium-induced hepatic oxidative damage in rats.

Protective effect of mannose oligosaccharides on cadmium-induced hepatic oxidative damage in rats.

Journal: Polish journal of veterinary sciences

Published: June 25, 2025

Discovery of a CYP2E1 inhibitor and its therapeutic potential in severe acute pancreatitis.

Discovery of a CYP2E1 inhibitor and its therapeutic potential in severe acute pancreatitis.

Journal: European journal of medicinal chemistry

Published: February 09, 2025

Identification of cytochrome P450 2E1 as a novel target in neuroinflammation and development of its inhibitor Q11 as a treatment strategy.

Identification of cytochrome P450 2E1 as a novel target in neuroinflammation and development of its inhibitor Q11 as a treatment strategy.

Journal: Free radical biology & medicine

Published: January 27, 2025

Treatment with mannose oligosaccharides reverses the intestinal injury in the acetylsalicylic acid-treated rat model.

Treatment with mannose oligosaccharides reverses the intestinal injury in the acetylsalicylic acid-treated rat model.

Journal: Polish journal of veterinary sciences

Published: December 30, 2024

Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance.

Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance.

Journal: Journal of gastrointestinal oncology

Published: December 10, 2024

Cytochrome P450 2E1 inhibitor Q11 is effective on hepatocellular carcinoma by promoting peritumor neutrophil chemotaxis.

Cytochrome P450 2E1 inhibitor Q11 is effective on hepatocellular carcinoma by promoting peritumor neutrophil chemotaxis.

Journal: International journal of biological macromolecules

Published: October 24, 2024

Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization.

Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization.

Journal: Cancer immunology, immunotherapy : CII

Published: October 20, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026